<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="letter"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Crit Care</journal-id><journal-title-group><journal-title>Critical Care</journal-title></journal-title-group><issn pub-type="ppub">1364-8535</issn><issn pub-type="epub">1466-609X</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">32456658</article-id><article-id pub-id-type="pmc">7249975</article-id><article-id pub-id-type="publisher-id">2995</article-id><article-id pub-id-type="doi">10.1186/s13054-020-02995-3</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Letter</subject></subj-group></article-categories><title-group><article-title>The association of low serum albumin level with severe COVID-19: a systematic review and meta-analysis</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5620-8597</contrib-id><name><surname>Aziz</surname><given-names>Muhammad</given-names></name><address><email>marajani@hotmail.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Fatima</surname><given-names>Rawish</given-names></name><address><email>Rawish.f@gmail.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Lee-Smith</surname><given-names>Wade</given-names></name><address><email>Wade.Lee@utoledo.edu</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Assaly</surname><given-names>Ragheb</given-names></name><address><email>ragheb.assaly@utoledo.edu</email></address><xref ref-type="aff" rid="Aff3">3</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.411726.7</institution-id><institution-id institution-id-type="ISNI">0000 0004 0628 5895</institution-id><institution>Department of Internal Medicine, </institution><institution>University of Toledo Medical Center, </institution></institution-wrap>Toledo, OH USA </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.411726.7</institution-id><institution-id institution-id-type="ISNI">0000 0004 0628 5895</institution-id><institution>University of Toledo Libraries, </institution><institution>University of Toledo Medical Center, </institution></institution-wrap>Toledo, OH USA </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.411726.7</institution-id><institution-id institution-id-type="ISNI">0000 0004 0628 5895</institution-id><institution>Division of Pulmonary and Critical Care Medicine, </institution><institution>University of Toledo Medical Center, </institution></institution-wrap>Toledo, OH USA </aff></contrib-group><pub-date pub-type="epub"><day>26</day><month>5</month><year>2020</year></pub-date><pub-date pub-type="pmc-release"><day>26</day><month>5</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>24</volume><elocation-id>255</elocation-id><history><date date-type="received"><day>4</day><month>5</month><year>2020</year></date><date date-type="accepted"><day>14</day><month>5</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2020</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p></license></permissions><kwd-group xml:lang="en"><title>Keywords</title><kwd>Hypoalbuminemia</kwd><kwd>COVID-19</kwd><kwd>SARS-CoV-2</kwd><kwd>Severe disease</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2020</meta-value></custom-meta></custom-meta-group></article-meta></front><body><p id="Par8">The coronavirus disease 2019 (COVID-19) pandemic necessitates identifying laboratory markers to assist the clinicians in early recognition of severe disease [<xref ref-type="bibr" rid="CR1">1</xref>]. Given the unclear association of hypoalbuminemia and severe COVID-19, we conducted a systematic review and meta-analysis to answer this.</p><p id="Par9">An extensive literature search of PubMed/MEDLINE, Embase, Cochrane, and Web of Science was conducted through April 3, 2020, using search strategy created by an experienced librarian (W.L.S). Two independent reviewers (M.A. and R.F.) performed screening and data extraction of articles. Articles were selected if they reported data on COVID-19 patients with respect to hypoalbuminemia. Discrepancy in screening/data collection was resolved through mutual discussion. Random-effects meta-analysis was conducted, and odds ratio (OR) and mean difference (MD) for proportional and continuous variables were computed, respectively. For each outcome, forest plot, 95% confidence interval (CI), <italic>p</italic> value (&#x0003c;&#x02009;0.05 considered statistically significant), and <italic>I</italic><sup>2</sup> statistic (&#x0003e;&#x02009;50% considered as substantial heterogeneity) was generated using Open Meta Analyst (CEBM, Oxford, UK).</p><p id="Par10">Severe COVID-19 was defined as respiratory distress (with either rate &#x02265;&#x02009;30/min, oxygen saturation &#x02264;&#x02009;93% at rest, and/or PaO2/FiO2 &#x02264;&#x02009;300&#x02009;mmHg), ICU admission, and/or death [<xref ref-type="bibr" rid="CR1">1</xref>]. Hypoalbuminemia was reported based on reference laboratory parameters for each study.</p><p id="Par11">A total of 11 studies (with 910 patients, mean age 47.6&#x02009;&#x000b1;&#x02009;8.2&#x02009;years and 47.0% females) were included (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). The weighted mean serum albumin on admission was 3.50&#x02009;g/dL (CI 3.26&#x02013;3.74&#x02009;g/dL) and 4.05&#x02009;g/dL (CI 3.82&#x02013;4.27&#x02009;g/dL) in severe and non-severe COVID-19 group, respectively. This was statistically significant (MD:&#x02212;&#x02009;0.56&#x02009;g/dL, CI -0.69 to -0.42&#x02009;g/dL, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001, <italic>I</italic><sup>2</sup>&#x02009;=&#x02009;91.2%)(Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>a). Leave-one-out meta-analysis was consistent with point estimate (MD) ranging from -0.61 to -0.51&#x02009;g/dL (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>b). The results were consistent on subgroup analysis of 8 studies that defined severe COVID-19 based on respiratory distress definition (MD -0.58&#x02009;g/dL, 95% CI -0.78 to -0.37&#x02009;g/dL, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001, <italic>I</italic><sup>2</sup>&#x02009;=&#x02009;87.9%). Four studies assessed the hypoalbuminemia status and severe COVID-19 and increased risk was demonstrated (OR 12.6, 95% CI 7.5&#x02013;21.1, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001, <italic>I</italic><sup>2</sup>&#x02009;=&#x02009;0%) (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>c).
<table-wrap id="Tab1"><label>Table 1</label><caption><p>Study characteristic and demographics of included patients (<italic>n</italic> no. of patients, <italic>NR</italic> not reported, <italic>SD</italic> standard deviation)</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Study, year</th><th rowspan="2">Country</th><th rowspan="2">Language</th><th rowspan="2">Hospital</th><th rowspan="2">Study period</th><th rowspan="2">Total patients</th><th rowspan="2">Mean/median age</th><th rowspan="2">Female gender,<italic>n</italic> (%)</th><th rowspan="2">Severe patients<sup>#</sup>, <italic>n</italic> (%)</th><th colspan="2">Serum albumin level, mean (SD) g/dL</th></tr><tr><th>Severe</th><th>Non-severe</th></tr></thead><tbody><tr><td>Huang, 2020 [<xref ref-type="bibr" rid="CR2">2</xref>]</td><td>China</td><td>English</td><td>Jinyintan Hospital</td><td>Dec 16 to Jan 2</td><td>41</td><td>49</td><td>11 (26.8%)</td><td>13 (31.7%)</td><td>2.83 (0.24)</td><td>3.4 (0.27)</td></tr><tr><td>Chen (1), 2020 [<xref ref-type="bibr" rid="CR3">3</xref>]</td><td>China</td><td>English</td><td>Tongji Hospital</td><td>Jan 13 to Feb 28</td><td>274</td><td>NR</td><td>NR</td><td>113 (41.2%)</td><td>3.03 (0.06)</td><td>3.65 (0.26)</td></tr><tr><td>Liu (1), 2020 [<xref ref-type="bibr" rid="CR4">4</xref>]</td><td>China</td><td>English</td><td>Shenzhen Third People&#x02019;s Hospital</td><td>Jan 11 to Jan 21</td><td>12</td><td>58.9</td><td>4 (33.3%)</td><td>6 (50.0%)</td><td>3.77 (0.25)</td><td>4.43 (0.34)</td></tr><tr><td>Chen (2), 2020 [<xref ref-type="bibr" rid="CR5">5</xref>]</td><td>China</td><td>English</td><td>Tongji Hospital</td><td>Dec to Jan 27</td><td>21</td><td>56</td><td>4 (19.0%)</td><td>11 (52.4%)</td><td>3.02 (0.24)</td><td>3.73 (0.22)</td></tr><tr><td>Mo, 2020 [<xref ref-type="bibr" rid="CR6">6</xref>]</td><td>China</td><td>English</td><td>Zhongnan Hospital</td><td>Jan 1 to Feb 5</td><td>155</td><td>54</td><td>69 (44.5%)</td><td>92 (59.4%)</td><td>3.6 (0.31)</td><td>3.9 (0.27)</td></tr><tr><td>Wan, 2020 [<xref ref-type="bibr" rid="CR7">7</xref>]</td><td>China</td><td>English</td><td>Chongqing University Three Gorges Hospital</td><td>Jan 23 to Feb 8</td><td>135</td><td>47</td><td>63 (46.7%)</td><td>40 (29.6%)</td><td>3.59 (0.26)</td><td>4.52 (0.27)</td></tr><tr><td>Liu (2), 2020 [<xref ref-type="bibr" rid="CR8">8</xref>]</td><td>China</td><td>Chinese</td><td>Multicenter</td><td>Jan 23 to Feb 8</td><td>32</td><td>38.5</td><td>12 (37.5%)</td><td>4 (12.5%)</td><td>3.55 (0.44)</td><td>4.05 (0.34)</td></tr><tr><td>Liu (3), 2020 [<xref ref-type="bibr" rid="CR9">9</xref>]</td><td>China</td><td>Chinese</td><td>Jianghan University Affiliated Hospital</td><td>Jan 10 to Jan 31</td><td>30</td><td>35</td><td>20 (66.7%)</td><td>4 (13.3%)</td><td>3.5 (0.21)</td><td>4.2 (0.28)</td></tr><tr><td>Liu (4), 2020 [<xref ref-type="bibr" rid="CR10">10</xref>]</td><td>China</td><td>English</td><td>Multicenter</td><td>Dec 30 to Jan 15</td><td>78</td><td>38</td><td>39 (50.0%)</td><td>11 (14.1%)</td><td>3.66 (0.43)</td><td>4.13 (0.33)</td></tr><tr><td>Zhang, 2020 [<xref ref-type="bibr" rid="CR11">11</xref>]</td><td>China</td><td>English</td><td>Zhongnan Hospital</td><td>Jan 18 to Feb 22</td><td>115</td><td>49.52</td><td>66 (57.4%)</td><td>31 (30.0%)</td><td>3.44 (0.31)</td><td>4.04 (0.28)</td></tr><tr><td>Zhou, 2020 [<xref ref-type="bibr" rid="CR12">12</xref>]</td><td>China</td><td>English</td><td>Ninth Hospital of Nanchang</td><td>Jan 28 to Feb 6</td><td>17</td><td>41.7</td><td>11 (64.7%)</td><td>5 (29.4%)</td><td>4.6 (0.28)</td><td>4.49 (0.27)</td></tr></tbody></table><table-wrap-foot><p><sup>#</sup>Respiratory distress (rate&#x02009;&#x02265;&#x02009;30/min, oxygen saturation&#x02009;&#x02264;&#x02009;93% at rest and/or PaO2/FiO2&#x02009;&#x02264;&#x02009;300&#x02009;mmHg), <italic>ICU</italic> admission and/or death</p></table-wrap-foot></table-wrap><fig id="Fig1"><label>Fig. 1</label><caption><p>Forest plot demonstrating <bold>a</bold> meta-analysis comparing mean serum albumin, <bold>b</bold> leave-one-out meta-analysis comparing mean serum albumin, and <bold>c</bold> meta-analysis comparing hypoalbuminemia status for patients in severe vs non-severe group (C.I. confidence interval)</p></caption><graphic xlink:href="13054_2020_2995_Fig1_HTML" id="MO1"/></fig></p><p id="Par12">Hypoalbuminemia status has been associated with critically ill patients and mortality across numerous clinical settings [<xref ref-type="bibr" rid="CR13">13</xref>]. The pathophysiology behind hypoalbuminemia in disease state (such as pancreatitis, infection, trauma, burn, and organ dysfunction) is thought to be secondary to increased capillary permeability, decreased protein synthesis, decreased half-life of serum albumin, decreased serum albumin total mass, increased volume of distribution, and increase expression of vascular endothelial growth factor [<xref ref-type="bibr" rid="CR14">14</xref>]. The hallmark of severe COVID-19 includes the cytokine storm and an interplay of some of the aforementioned mechanisms [<xref ref-type="bibr" rid="CR1">1</xref>].</p><p id="Par13">Our study had some limitations. There was lack of reporting on temporal association of hypoalbuminemia and severe COVID-19. The serum albumin level was noted on admission; however, it is difficult to make conclusive evidence whether severe COVID-19 caused hypoalbuminemia or vice versa. We were also not able to address if hypoalbuminemia should be corrected or not in the current study and needs further evaluation in future studies. The strength of our study is the reporting of large cohort of patients with consistent results across subgroup and sensitivity analysis.</p><p id="Par14">We demonstrate the association of hypoalbuminemia and severe COVID-19. A low albumin level can potentially lead to early recognition of severe disease and assist clinicians in making informed decision for their patients.</p></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>CI</term><def><p id="Par1">Confidence interval</p></def></def-item><def-item><term>COVID-19</term><def><p id="Par2">Coronavirus disease 2019</p></def></def-item><def-item><term>ICU</term><def><p id="Par3">Intensive care unit</p></def></def-item><def-item><term>MD</term><def><p id="Par4">Mean difference</p></def></def-item><def-item><term><italic>n</italic></term><def><p id="Par5">No. of patients</p></def></def-item><def-item><term>OR</term><def><p id="Par6">odds ratio</p></def></def-item><def-item><term>SD</term><def><p id="Par7">standard deviation</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Publisher&#x02019;s Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>None</p></ack><notes notes-type="author-contribution"><title>Authors&#x02019; contributions</title><p>Muhammad Aziz: planning and conducting the study, collecting, interpreting data, statistical analysis, drafting the manuscript. Rawish Fatima: collecting data, drafting the manuscript. Wade lee-smith: created the search strategy and critical revision of manuscript. Ragheb Assaly: study design and conception, critical revision of the manuscript. The authors read and approved the final manuscript</p></notes><notes notes-type="funding-information"><title>Funding</title><p>No funding received for preparing this manuscript.</p></notes><notes notes-type="data-availability"><title>Availability of data and materials</title><p>The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.</p></notes><notes id="FPar1"><title>Ethics approval and consent to participate</title><p id="Par15">Not obtained as this is a systematic review and meta-analysis of published studies.</p></notes><notes id="FPar2"><title>Consent for publication</title><p id="Par16">Consent from patients not obtained due to reason above. All authors approved for the submission of the manuscript.</p></notes><notes id="FPar3" notes-type="COI-statement"><title>Competing interests</title><p id="Par17">The authors declare no competing/conflict of interest.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><mixed-citation publication-type="other">Aziz M, Fatima R, Assaly R. Elevated interleukin-6 and severe COVID-19: a meta-analysis. J Med Virol. 2020. 10.1002/jmv.25948.</mixed-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>Chaolin</given-names></name><name><surname>Wang</surname><given-names>Yeming</given-names></name><name><surname>Li</surname><given-names>Xingwang</given-names></name><name><surname>Ren</surname><given-names>Lili</given-names></name><name><surname>Zhao</surname><given-names>Jianping</given-names></name><name><surname>Hu</surname><given-names>Yi</given-names></name><name><surname>Zhang</surname><given-names>Li</given-names></name><name><surname>Fan</surname><given-names>Guohui</given-names></name><name><surname>Xu</surname><given-names>Jiuyang</given-names></name><name><surname>Gu</surname><given-names>Xiaoying</given-names></name><name><surname>Cheng</surname><given-names>Zhenshun</given-names></name><name><surname>Yu</surname><given-names>Ting</given-names></name><name><surname>Xia</surname><given-names>Jiaan</given-names></name><name><surname>Wei</surname><given-names>Yuan</given-names></name><name><surname>Wu</surname><given-names>Wenjuan</given-names></name><name><surname>Xie</surname><given-names>Xuelei</given-names></name><name><surname>Yin</surname><given-names>Wen</given-names></name><name><surname>Li</surname><given-names>Hui</given-names></name><name><surname>Liu</surname><given-names>Min</given-names></name><name><surname>Xiao</surname><given-names>Yan</given-names></name><name><surname>Gao</surname><given-names>Hong</given-names></name><name><surname>Guo</surname><given-names>Li</given-names></name><name><surname>Xie</surname><given-names>Jungang</given-names></name><name><surname>Wang</surname><given-names>Guangfa</given-names></name><name><surname>Jiang</surname><given-names>Rongmeng</given-names></name><name><surname>Gao</surname><given-names>Zhancheng</given-names></name><name><surname>Jin</surname><given-names>Qi</given-names></name><name><surname>Wang</surname><given-names>Jianwei</given-names></name><name><surname>Cao</surname><given-names>Bin</given-names></name></person-group><article-title>Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China</article-title><source>The Lancet</source><year>2020</year><volume>395</volume><issue>10223</issue><fpage>497</fpage><lpage>506</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(20)30183-5</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><mixed-citation publication-type="other">Chen T, Wu D, Chen H, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020;368:m1091. 10.1136/bmj.m1091.</mixed-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Yingxia</given-names></name><name><surname>Yang</surname><given-names>Yang</given-names></name><name><surname>Zhang</surname><given-names>Cong</given-names></name><name><surname>Huang</surname><given-names>Fengming</given-names></name><name><surname>Wang</surname><given-names>Fuxiang</given-names></name><name><surname>Yuan</surname><given-names>Jing</given-names></name><name><surname>Wang</surname><given-names>Zhaoqin</given-names></name><name><surname>Li</surname><given-names>Jinxiu</given-names></name><name><surname>Li</surname><given-names>Jianming</given-names></name><name><surname>Feng</surname><given-names>Cheng</given-names></name><name><surname>Zhang</surname><given-names>Zheng</given-names></name><name><surname>Wang</surname><given-names>Lifei</given-names></name><name><surname>Peng</surname><given-names>Ling</given-names></name><name><surname>Chen</surname><given-names>Li</given-names></name><name><surname>Qin</surname><given-names>Yuhao</given-names></name><name><surname>Zhao</surname><given-names>Dandan</given-names></name><name><surname>Tan</surname><given-names>Shuguang</given-names></name><name><surname>Yin</surname><given-names>Lu</given-names></name><name><surname>Xu</surname><given-names>Jun</given-names></name><name><surname>Zhou</surname><given-names>Congzhao</given-names></name><name><surname>Jiang</surname><given-names>Chengyu</given-names></name><name><surname>Liu</surname><given-names>Lei</given-names></name></person-group><article-title>Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury</article-title><source>Science China Life Sciences</source><year>2020</year><volume>63</volume><issue>3</issue><fpage>364</fpage><lpage>374</lpage><pub-id pub-id-type="doi">10.1007/s11427-020-1643-8</pub-id><pub-id pub-id-type="pmid">32048163</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Guang</given-names></name><name><surname>Wu</surname><given-names>Di</given-names></name><name><surname>Guo</surname><given-names>Wei</given-names></name><name><surname>Cao</surname><given-names>Yong</given-names></name><name><surname>Huang</surname><given-names>Da</given-names></name><name><surname>Wang</surname><given-names>Hongwu</given-names></name><name><surname>Wang</surname><given-names>Tao</given-names></name><name><surname>Zhang</surname><given-names>Xiaoyun</given-names></name><name><surname>Chen</surname><given-names>Huilong</given-names></name><name><surname>Yu</surname><given-names>Haijing</given-names></name><name><surname>Zhang</surname><given-names>Xiaoping</given-names></name><name><surname>Zhang</surname><given-names>Minxia</given-names></name><name><surname>Wu</surname><given-names>Shiji</given-names></name><name><surname>Song</surname><given-names>Jianxin</given-names></name><name><surname>Chen</surname><given-names>Tao</given-names></name><name><surname>Han</surname><given-names>Meifang</given-names></name><name><surname>Li</surname><given-names>Shusheng</given-names></name><name><surname>Luo</surname><given-names>Xiaoping</given-names></name><name><surname>Zhao</surname><given-names>Jianping</given-names></name><name><surname>Ning</surname><given-names>Qin</given-names></name></person-group><article-title>Clinical and immunological features of severe and moderate coronavirus disease 2019</article-title><source>Journal of Clinical Investigation</source><year>2020</year><volume>130</volume><issue>5</issue><fpage>2620</fpage><lpage>2629</lpage><pub-id pub-id-type="doi">10.1172/JCI137244</pub-id><pub-id pub-id-type="pmid">32217835</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><mixed-citation publication-type="other">Mo P, Xing Y, Xiao Y, et al. Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China.&#x000a0;Clin Infect Dis. 2020;ciaa270. 10.1093/cid/ciaa270.</mixed-citation></ref><ref id="CR7"><label>7.</label><mixed-citation publication-type="other">Wan S, Xiang Y, Fang W, et al. Clinical features and treatment of COVID-19 patients in northeast Chongqing. J Med Virol. 2020;10.1002/jmv.25783.&#x000a0;.</mixed-citation></ref><ref id="CR8"><label>8.</label><mixed-citation publication-type="other">Liu C, Jiang ZC, Shao CX, et al. Zhonghua Gan Zang Bing Za Zhi. 2020;28:107&#x02013;11. 10.3760/cma.j.issn.1007-3418.2020.02.003.</mixed-citation></ref><ref id="CR9"><label>9.</label><mixed-citation publication-type="other">Liu M, He P, Liu HG, et al. Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E016. 10.3760/cma.j.issn.1001-0939.2020.0016.</mixed-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Wei</given-names></name><name><surname>Tao</surname><given-names>Zhao-Wu</given-names></name><name><surname>Wang</surname><given-names>Lei</given-names></name><name><surname>Yuan</surname><given-names>Ming-Li</given-names></name><name><surname>Liu</surname><given-names>Kui</given-names></name><name><surname>Zhou</surname><given-names>Ling</given-names></name><name><surname>Wei</surname><given-names>Shuang</given-names></name><name><surname>Deng</surname><given-names>Yan</given-names></name><name><surname>Liu</surname><given-names>Jing</given-names></name><name><surname>Liu</surname><given-names>Hui-Guo</given-names></name><name><surname>Yang</surname><given-names>Ming</given-names></name><name><surname>Hu</surname><given-names>Yi</given-names></name></person-group><article-title>Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease</article-title><source>Chinese Medical Journal</source><year>2020</year><volume>133</volume><issue>9</issue><fpage>1032</fpage><lpage>1038</lpage><pub-id pub-id-type="doi">10.1097/CM9.0000000000000775</pub-id><pub-id pub-id-type="pmid">32118640</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><mixed-citation publication-type="other">Zhang Y, Zheng L, Liu L, Zhao M, Xiao J, Zhao Q. Liver impairment in COVID-19 patients: A retrospective analysis of 115 cases from a single centre in Wuhan city, China. Liver Int. 2020;10.1111/liv.14455. 10.1111/liv.14455.</mixed-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Yulong</given-names></name><name><surname>Zhang</surname><given-names>Zhicheng</given-names></name><name><surname>Tian</surname><given-names>Jie</given-names></name><name><surname>Xiong</surname><given-names>Shaoyun</given-names></name></person-group><article-title>Risk factors associated with disease progression in a cohort of patients infected with the 2019 novel coronavirus</article-title><source>Annals of Palliative Medicine</source><year>2020</year><volume>9</volume><issue>2</issue><fpage>428</fpage><lpage>436</lpage><pub-id pub-id-type="doi">10.21037/apm.2020.03.26</pub-id><pub-id pub-id-type="pmid">32233642</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akirov</surname><given-names>Amit</given-names></name><name><surname>Masri-Iraqi</surname><given-names>Hiba</given-names></name><name><surname>Atamna</surname><given-names>Alaa</given-names></name><name><surname>Shimon</surname><given-names>Ilan</given-names></name></person-group><article-title>Low Albumin Levels Are Associated with Mortality Risk in Hospitalized Patients</article-title><source>The American Journal of Medicine</source><year>2017</year><volume>130</volume><issue>12</issue><fpage>1465.e11-1465.e19</fpage><pub-id pub-id-type="doi">10.1016/j.amjmed.2017.07.020</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soeters</surname><given-names>Peter B.</given-names></name><name><surname>Wolfe</surname><given-names>Robert R.</given-names></name><name><surname>Shenkin</surname><given-names>Alan</given-names></name></person-group><article-title>Hypoalbuminemia: Pathogenesis and Clinical Significance</article-title><source>Journal of Parenteral and Enteral Nutrition</source><year>2018</year><volume>43</volume><issue>2</issue><fpage>181</fpage><lpage>193</lpage><pub-id pub-id-type="doi">10.1002/jpen.1451</pub-id><pub-id pub-id-type="pmid">30288759</pub-id></element-citation></ref></ref-list></back></article>